Drug Shortage Report for METHOTREXATE INJECTION USP

Last updated on 2018-02-23 History
Report ID 32130
Drug Identification Number 02182777
Brand name METHOTREXATE INJECTION USP
Common or Proper name METHOTREXATE
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) METHOTREXATE
Strength(s) 25MG
Dosage form(s) SOLUTION
Route of administration INTRA-ARTERIAL INTRAMUSCULAR INTRAVENOUS
Packaging size 5 x 2mL
ATC code L01BA
ATC description ANTIMETABOLITES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2018-03-30
Actual start date
Estimated end date
Actual end date 2018-02-22
Shortage status Avoided shortage
Updated date 2018-02-23
Company comments
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2017-12-08 English Compare
v2 2017-12-08 English Compare
v3 2017-12-08 French Compare
v4 2018-02-11 English Compare
v5 2018-02-23 English Compare
v6 2018-02-23 French Compare
v7 2018-02-23 English Compare
v8 2018-02-23 French Compare